Solid Biosciences, Inc. (SLDB)
9.72
-0.17
(-1.72%)
USD |
NASDAQ |
Aug 26, 16:00
9.53
-0.19
(-1.95%)
After-Hours: 20:00
Solid Biosciences 1 Year Total Returns (Daily) : 70.23% for Aug. 26, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 26, 2026 | 70.23% |
| August 25, 2026 | 76.61% |
| August 24, 2026 | 54.47% |
| August 21, 2026 | 64.31% |
| August 20, 2026 | 60.78% |
| August 19, 2026 | 67.93% |
| August 18, 2026 | 50.58% |
| August 17, 2026 | 48.94% |
| August 14, 2026 | 49.11% |
| August 13, 2026 | 35.93% |
| August 12, 2026 | 50.08% |
| August 11, 2026 | 45.56% |
| August 10, 2026 | 36.09% |
| August 07, 2026 | 35.54% |
| August 06, 2026 | 33.79% |
| August 05, 2026 | 30.30% |
| August 04, 2026 | 26.39% |
| August 03, 2026 | 17.42% |
| July 31, 2026 | 17.84% |
| July 30, 2026 | 20.08% |
| July 29, 2026 | 13.72% |
| July 28, 2026 | 13.53% |
| July 27, 2026 | 12.71% |
| July 24, 2026 | 17.22% |
| July 23, 2026 | 18.05% |
| Date | Value |
|---|---|
| July 22, 2026 | 30.02% |
| July 21, 2026 | 32.81% |
| July 20, 2026 | 32.24% |
| July 17, 2026 | 50.60% |
| July 16, 2026 | 62.19% |
| July 15, 2026 | 78.48% |
| July 14, 2026 | 76.05% |
| July 13, 2026 | 84.79% |
| July 10, 2026 | 92.25% |
| July 09, 2026 | 101.8% |
| July 08, 2026 | 109.9% |
| July 07, 2026 | 127.1% |
| July 06, 2026 | 120.1% |
| July 02, 2026 | 122.6% |
| July 01, 2026 | 121.7% |
| June 30, 2026 | 105.1% |
| June 29, 2026 | 100.6% |
| June 26, 2026 | 93.14% |
| June 25, 2026 | 86.92% |
| June 24, 2026 | 90.53% |
| June 23, 2026 | 94.90% |
| June 22, 2026 | 73.28% |
| June 18, 2026 | 79.14% |
| June 17, 2026 | 58.57% |
| June 16, 2026 | 40.84% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Agenus, Inc. | 78.19% |
| Amgen, Inc. | 56.26% |
| Anika Therapeutics, Inc. | 132.4% |
| BioCryst Pharmaceuticals, Inc. | 14.57% |
| Imunon, Inc. | -73.88% |